Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 4
2013 1
2014 2
2016 2
2018 1
2019 2
2020 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean taniguchi y[Author] (2,363 results)?
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.
Kotajima-Murakami H, Takano A, Hirakawa S, Ogai Y, Funada D, Tanibuchi Y, Ban E, Kikuchi M, Tachimori H, Maruo K, Kawashima T, Tomo Y, Sasaki T, Oi H, Matsumoto T, Ikeda K. Kotajima-Murakami H, et al. Among authors: tanibuchi y. Neuropsychopharmacol Rep. 2022 Mar;42(1):92-104. doi: 10.1002/npr2.12232. Epub 2022 Jan 23. Neuropsychopharmacol Rep. 2022. PMID: 35068087 Free PMC article. Clinical Trial.
Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
Kotajima-Murakami H, Takano A, Ogai Y, Tsukamoto S, Murakami M, Funada D, Tanibuchi Y, Tachimori H, Maruo K, Sasaki T, Matsumoto T, Ikeda K. Kotajima-Murakami H, et al. Among authors: tanibuchi y. Neuropsychopharmacol Rep. 2019 Jun;39(2):90-99. doi: 10.1002/npr2.12050. Epub 2019 Feb 12. Neuropsychopharmacol Rep. 2019. PMID: 30756527 Free PMC article. Clinical Trial.
Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis-related psychiatric disorders.
Matsumoto T, Kawabata T, Okita K, Tanibuchi Y, Funada D, Murakami M, Usami T, Yokoyama R, Naruse N, Aikawa Y, Furukawa A, Komatsuzaki C, Hashimoto N, Fujita O, Umemoto A, Kagaya A, Shimane T. Matsumoto T, et al. Among authors: tanibuchi y. Neuropsychopharmacol Rep. 2020 Dec;40(4):332-341. doi: 10.1002/npr2.12133. Epub 2020 Sep 7. Neuropsychopharmacol Rep. 2020. PMID: 32896111 Free PMC article.
Changes of clinical symptoms in patients with new psychoactive substance (NPS)-related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction.
Funada D, Matsumoto T, Tanibuchi Y, Kawasoe Y, Sakakibara S, Naruse N, Ikeda S, Sunami T, Muto T, Cho T. Funada D, et al. Among authors: tanibuchi y. Neuropsychopharmacol Rep. 2019 Jun;39(2):119-129. doi: 10.1002/npr2.12053. Epub 2019 Apr 9. Neuropsychopharmacol Rep. 2019. PMID: 30968601 Free PMC article.
Recent changes in the clinical features of patients with new psychoactive-substances-related disorders in Japan: Comparison of the Nationwide Mental Hospital Surveys on Drug-related Psychiatric Disorders undertaken in 2012 and 2014.
Matsumoto T, Tachimori H, Takano A, Tanibuchi Y, Funada D, Wada K. Matsumoto T, et al. Among authors: tanibuchi y. Psychiatry Clin Neurosci. 2016 Dec;70(12):560-566. doi: 10.1111/pcn.12434. Epub 2016 Sep 29. Psychiatry Clin Neurosci. 2016. PMID: 27527499 Free article.
17 results